Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Treponema pallidum | NADH oxidase | 0.0016 | 0 | 0.5 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0016 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0105 | 0.6806 | 0.8837 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0046 | 0.2299 | 0.6262 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0656 | 0.1788 |
Plasmodium falciparum | glutathione reductase | 0.0046 | 0.2299 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0117 | 0.7701 | 1 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0105 | 0.6806 | 0.8837 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0046 | 0.2299 | 0.5449 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0046 | 0.2299 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0 | 0.5 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0046 | 0.2299 | 0.6262 |
Plasmodium vivax | glutathione reductase, putative | 0.0046 | 0.2299 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0117 | 0.7701 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0656 | 0.2855 |
Loa Loa (eye worm) | RNA binding protein | 0.0064 | 0.3671 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.2312 | 0.6298 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0016 | 0 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0656 | 0.2855 |
Brugia malayi | Thioredoxin reductase | 0.0046 | 0.2299 | 0.6262 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0046 | 0.2312 | 0.5492 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0016 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.2312 | 0.2312 |
Leishmania major | trypanothione reductase | 0.0046 | 0.2299 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0064 | 0.3671 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0064 | 0.3671 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0046 | 0.2299 | 0.5449 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.2312 | 0.2312 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3671 | 0.3671 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0117 | 0.7701 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0016 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3671 | 0.3671 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0656 | 0.2855 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0105 | 0.6806 | 0.8837 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.0656 | 0.2855 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.0656 | 0.2855 |
Loa Loa (eye worm) | TAR-binding protein | 0.0064 | 0.3671 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.2312 | 0.6298 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0656 | 0.2855 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0105 | 0.6806 | 0.8837 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0064 | 0.3671 | 1 |
Brugia malayi | TAR-binding protein | 0.0064 | 0.3671 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0046 | 0.2299 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0016 | 0 | 0.5 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0046 | 0.2299 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.0656 | 0.2855 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0117 | 0.7701 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0105 | 0.6806 | 0.8837 |
Brugia malayi | RNA binding protein | 0.0064 | 0.3671 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0046 | 0.2312 | 0.6298 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3671 | 0.3671 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3671 | 0.3671 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0016 | 0 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.0656 | 0.2855 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0016 | 0 | 0.5 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0046 | 0.2299 | 0.2985 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.2312 | 0.2312 |
Toxoplasma gondii | thioredoxin reductase | 0.0046 | 0.2299 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0046 | 0.2299 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3671 | 0.3671 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0064 | 0.3671 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0105 | 0.6806 | 0.8837 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.2312 | 0.6298 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.2312 | 0.6298 |
Brugia malayi | glutathione reductase | 0.0046 | 0.2299 | 0.6262 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.